8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Brain Ischemia in 1 studies
8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd
Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, SJ | 1 |
| Hwang, JH | 1 |
1 other study available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Brain Ischemia
| Article | Year |
|---|---|
Reduction of neuronal damage in ischemic stroke using a combination therapy of TMB-8 with L-arginine.
Topics: Animals; Arginine; Brain Ischemia; Calcium; Calcium Channel Blockers; Drug Therapy, Combination; Gal | 2000 |